From: Stroke epidemiology and outcomes of stroke patients in Nepal: a systematic review and meta-analysis
STUDY | Disability/outcomes |
---|---|
Cherian I. et al. 2018 [32] | GOS Moderate disability at 6 weeks = 28/102 (27.5%) |
Dhungana K et al. 2019 [49] | At discharge, mRS 1 = 10/96 mRS 2 = 36/96 mRS 3 = 35/96 mRS 4 = 11/96 mRS 5 = 4/96 |
Gajurel BP et al. 2014 [50] | Mean MRS score at 1 month = 3.58 ± 1.5 mRS 0 = 1/101 mRS 1 = 5/101 mRS 2 = 18 mRS 3 = 34 mRS 4 = 15 mRS 5 = 9 mRS 6 = 19 |
Jwarchan B et al. 2020 [35] | Association of comorbidities with good outcome mRS 0–1 and poor outcome mRS 2–6 seen |
Karn R et al. 2018 [51] | Mean mRS score at 1 month = 2.66 ± 1.803 Mean mRS score at 6 months = 2.71 ± 2.013 |
Khattar NK et al. 2019 [36] | At discharge, GOS 1 = 12/21 GOS 2–4 = 7/21 GOS 5 = 2/21 |
Poudel RS et al. 2015 [21] | At 3 months, No symptoms at all (mRS 0) = 4/37 No significant disability (mRS 1) = 9/37 Slight disability (mRS 2) = 7/37 Moderate disability (mRS 3) = 5/37 Moderate severe disability (mRS 4) = 4/37 Death (mRS 6) = 8/37 |
Shah B et al. 2020 [56] | At 1 month of stroke onset, Total functional dependence = 5/60 Partial functional dependence = 19/60 Independent = 11/60 Total functional dependence = 25/60 |
Shrestha S et al. 2015 [57] | At 3 months, Independent = 29/56 Dependent = 11/56 Death = 16/56 |
Shrestha R et al. 2018 [43] | At discharge, mRS 4 = 12/12 At 3 months, mRS 2 = 7/12, mRS 3 = 5/12 |
Thapa L et al. 2016 [44] | At discharge, mRS 0 = 4/9, mRS 3 = 2/9, mRS 4 = 1/9, mRS 5 = 2/9 |
Thapa A et al. 2018 [45] | At discharge, mRS < 2 = 558/946 (58.9%) At the end of 3 years, mRS < 2 = 115/130 (88.5%) |
Shakya D et al. 2019 [27] | WHODAS mean score = 46.0 ± 23.6 HRQOLISP mean score = 60.6 ± 13.6 |